• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾肿瘤中的上皮-间质转化

Epithelial-to-mesenchymal transition in renal neoplasms.

作者信息

He Huiying, Magi-Galluzzi Cristina

机构信息

*Department of Pathology, Peking University, Health Science Center, Beijing, China †Department of Pathology, R.T. Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.

出版信息

Adv Anat Pathol. 2014 May;21(3):174-80. doi: 10.1097/PAP.0000000000000018.

DOI:10.1097/PAP.0000000000000018
PMID:24713987
Abstract

Epithelial-to-mesenchymal transition (EMT) describes a phenotypical change induced in epithelial cells that lose their cell-cell basement membrane contacts and their structural polarity to become spindle-shaped and morphologically similar to mesenchymal/myofibroblast cell. The abnormal induction of EMT has been demonstrated to contribute to cancer dissemination and progression. Renal cell carcinoma (RCC) with sarcomatoid differentiation (sarcomatoid RCC) represents a good example of EMT both morphologically and immunohistochemically. Early spindle cell changes can at times be identified in RCC and likely represent an early step toward EMT. Herein, we present a review of the current understanding of EMT in renal neoplasms including some known signaling regulation, the association of sarcomatoid differentiation in RCC with aggressive behavior and dismal prognosis, and EMT-related tumor biology in sarcomatoid RCC. A better perception of the EMT may contribute toward an improved understanding of the development of sarcomatoid RCC. In addition, a distinct signature for sarcomatoid RCC may have utility in the differential diagnosis for prognostic stratification as well as in identifying novel genes and pathway targets for therapeutic intervention.

摘要

上皮-间质转化(EMT)描述了上皮细胞中发生的一种表型变化,这些细胞失去细胞间基底膜接触和结构极性,变成纺锤形,在形态上类似于间充质/肌成纤维细胞。EMT的异常诱导已被证明与癌症的扩散和进展有关。具有肉瘤样分化的肾细胞癌(肉瘤样肾细胞癌)在形态学和免疫组织化学方面都是EMT的一个很好例子。早期纺锤体细胞变化有时可在肾细胞癌中发现,可能代表了向EMT的早期步骤。在此,我们综述了目前对肾肿瘤中EMT的理解,包括一些已知的信号调节、肉瘤样肾细胞癌中肉瘤样分化与侵袭性行为和不良预后的关联,以及肉瘤样肾细胞癌中与EMT相关的肿瘤生物学。对EMT的更好理解可能有助于更好地了解肉瘤样肾细胞癌的发展。此外,肉瘤样肾细胞癌的独特特征可能在预后分层的鉴别诊断以及识别治疗干预的新基因和通路靶点方面具有实用价值。

相似文献

1
Epithelial-to-mesenchymal transition in renal neoplasms.肾肿瘤中的上皮-间质转化
Adv Anat Pathol. 2014 May;21(3):174-80. doi: 10.1097/PAP.0000000000000018.
2
Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition.透明细胞肾细胞癌的肉瘤样转化与上皮-间充质转化的关系。
Hum Pathol. 2012 May;43(5):708-19. doi: 10.1016/j.humpath.2011.06.019. Epub 2011 Oct 10.
3
Sarcomatoid renal cell carcinoma is an example of epithelial--mesenchymal transition.肉瘤样肾细胞癌是上皮-间充质转化的一个例子。
J Clin Pathol. 2011 Dec;64(12):1088-92. doi: 10.1136/jclinpath-2011-200216. Epub 2011 Oct 16.
4
Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma.成人肾细胞癌伴横纹肌样形态学表现为一种类似于肉瘤样癌的肿瘤去分化。
Ann Diagn Pathol. 2011 Oct;15(5):333-7. doi: 10.1016/j.anndiagpath.2011.03.002. Epub 2011 Jun 12.
5
Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.全面上皮-间充质转化基因集在肾细胞癌中的表达及预后意义。
J Urol. 2014 Feb;191(2):479-86. doi: 10.1016/j.juro.2013.08.052. Epub 2013 Sep 5.
6
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy.肾细胞癌中的上皮-间质转化:对癌症治疗的启示
Mol Diagn Ther. 2016 Apr;20(2):111-7. doi: 10.1007/s40291-016-0192-5.
7
Markers of epithelial-mesenchymal transition in renal cell carcinoma.肾细胞癌中上皮-间质转化的标志物
Exp Oncol. 2013 Dec;35(4):325-7.
8
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.嫌色细胞肾细胞癌(RCC):大型多中心系列中的肿瘤学结果和预后因素。
BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.
9
Re: epithelial-to-mesenchymal transition in renal neoplasms.关于:肾肿瘤中的上皮-间质转化
Eur Urol. 2015 Oct;68(4):736-7. doi: 10.1016/j.eururo.2015.06.031.
10
Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art.肉瘤样肾细胞癌的流行病学、生物学和治疗:当前的最新进展。
World J Urol. 2019 Jan;37(1):115-123. doi: 10.1007/s00345-018-2355-y. Epub 2018 Jun 1.

引用本文的文献

1
The role of adherent-to-suspension transition factors in clear cell renal cell carcinoma progression: a comprehensive analysis.贴壁-悬浮转变因子在透明细胞肾细胞癌进展中的作用:一项综合分析。
Sci Rep. 2025 Apr 19;15(1):13618. doi: 10.1038/s41598-025-96807-9.
2
Trends and Outcomes in Sarcomatoid Renal Cell Carcinoma: Analysis of the National Cancer Data Base.肉瘤样肾细胞癌的趋势与预后:国家癌症数据库分析
Eur Urol Open Sci. 2024 Dec 13;71:96-105. doi: 10.1016/j.euros.2024.10.002. eCollection 2025 Jan.
3
Identify BCAT1 plays an oncogenic role and promotes EMT in KIRC via single cell RNA-seq and experiment.
通过单细胞RNA测序和实验确定BCAT1发挥致癌作用并促进肾透明细胞癌中的上皮-间质转化。
Front Oncol. 2024 Sep 11;14:1446324. doi: 10.3389/fonc.2024.1446324. eCollection 2024.
4
IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis.IFI16 通过 IL6/PI3K/AKT 轴促进肾透明细胞癌的进展。
J Transl Med. 2024 Jun 3;22(1):533. doi: 10.1186/s12967-024-05354-w.
5
Poria acid inhibit the growth and metastasis of renal cell carcinoma by inhibiting the PI3K/akt/NF-κb signaling pathway.茯苓酸通过抑制PI3K/akt/NF-κb信号通路抑制肾细胞癌的生长和转移。
Heliyon. 2024 May 11;10(10):e31106. doi: 10.1016/j.heliyon.2024.e31106. eCollection 2024 May 30.
6
Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma.肾细胞癌中酪氨酸激酶抑制剂耐药的机制
Cancer Drug Resist. 2023 Dec 28;6(4):858-873. doi: 10.20517/cdr.2023.89. eCollection 2023.
7
Free-fatty acid receptor-1 (FFA1/GPR40) promotes papillary RCC proliferation and tumor growth via Src/PI3K/AKT/NF-κB but suppresses migration by inhibition of EGFR, ERK1/2, STAT3 and EMT.游离脂肪酸受体-1(FFA1/GPR40)通过Src/PI3K/AKT/NF-κB促进乳头状肾细胞癌增殖和肿瘤生长,但通过抑制表皮生长因子受体(EGFR)、细胞外信号调节激酶1/2(ERK1/2)、信号转导和转录激活因子3(STAT3)以及上皮-间质转化(EMT)来抑制迁移。
Cancer Cell Int. 2023 Jun 24;23(1):126. doi: 10.1186/s12935-023-02967-x.
8
Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study.肿瘤微环境异质性与非透明细胞肾细胞癌的临床预后相关:一项单细胞基因组学研究。
Cell Death Dis. 2022 Jan 11;13(1):50. doi: 10.1038/s41419-022-04501-9.
9
Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌对免疫治疗和抗血管生成治疗耐药的分子机制
Cancers (Basel). 2021 Nov 28;13(23):5981. doi: 10.3390/cancers13235981.
10
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma.转移性肾细胞癌中对 VEGFR-TKI 和免疫检查点抑制剂耐药的决定因素。
J Exp Clin Cancer Res. 2021 Jun 7;40(1):186. doi: 10.1186/s13046-021-01961-3.